---
figid: PMC6108866__IJMM-42-04-1771-g03
figtitle: Role of EpCAM in cell signaling
organisms:
- Mus musculus
- Rattus norvegicus
- Danio rerio
- Xenopus laevis
- Homo sapiens
- Canis lupus familiaris
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Canis lupus familiaris
- Danio rerio
- Xenopus laevis
- Drosophila melanogaster
pmcid: PMC6108866
filename: IJMM-42-04-1771-g03.jpg
figlink: /pmc/articles/PMC6108866/figure/f4-ijmm-42-04-1771/
number: F4
caption: 'Overview of the role of EpCAM in cell signaling. From the available data,
  EpCAM has emerged as a crucial signaling molecule, controlling four independent
  pathways. i) The nPKC-dependent pathway: The EpCAM cytoplasmic tail inhibits the
  nPKC activity and ERK pathway to protect cadherin-mediated adhesion. ii) Wnt signal
  pathway: EpCAM extracellular domain directly binds to Kremen1 and disrupts the Kremen1-Dkk2
  interaction, which prevents Kremen1-Dkk2-mediated removal of Lrp6 from the cell
  surface. EpCAM derepresses Lrp6 and cooperates with Wnt ligand to activate the Wnt
  signaling through stabilizing membrane Lrp6 and allowing Lrp6 to cluster into active
  signalosomes. iii) ERas/AKT pathway: EpCAM fosters the activating phosphory-lation
  of AKT at serine473 by interacting with hyperactive Ras GTPase ERas, which induces
  the activation of AKT. iv) In tumor cells or ES cells, EpICD forms a transcription
  activator complex with FHL2, β-Catenin and LEF-1 to increase transcription of EpCAM
  target genes, such as c-Myc and Cyclins A/E. Dkk2, Dickkopf2; Lrp6, Lipoprotein-receptor-related
  protein 6; EpCAM, epithelial cell adhesion molecule; PKC, protein kinase C; ERK,
  extracellular signal regulated kinase; ERas, embryonic Ras; AKT, RAC-α serine/threonine-protein
  kinase; EpICD, intracellular domain of EpCAM; FHL, four and a half LIM domains;
  LEF-1, lymphoid enhancer binding factor 1.'
papertitle: Functions of EpCAM in physiological processes and diseases (Review).
reftext: Li Huang, et al. Int J Mol Med. 2018 Oct;42(4):1771-1785.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.94813
figid_alias: PMC6108866__F4
figtype: Figure
redirect_from: /figures/PMC6108866__F4
ndex: 333c46eb-defa-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6108866__IJMM-42-04-1771-g03.html
  '@type': Dataset
  description: 'Overview of the role of EpCAM in cell signaling. From the available
    data, EpCAM has emerged as a crucial signaling molecule, controlling four independent
    pathways. i) The nPKC-dependent pathway: The EpCAM cytoplasmic tail inhibits the
    nPKC activity and ERK pathway to protect cadherin-mediated adhesion. ii) Wnt signal
    pathway: EpCAM extracellular domain directly binds to Kremen1 and disrupts the
    Kremen1-Dkk2 interaction, which prevents Kremen1-Dkk2-mediated removal of Lrp6
    from the cell surface. EpCAM derepresses Lrp6 and cooperates with Wnt ligand to
    activate the Wnt signaling through stabilizing membrane Lrp6 and allowing Lrp6
    to cluster into active signalosomes. iii) ERas/AKT pathway: EpCAM fosters the
    activating phosphory-lation of AKT at serine473 by interacting with hyperactive
    Ras GTPase ERas, which induces the activation of AKT. iv) In tumor cells or ES
    cells, EpICD forms a transcription activator complex with FHL2, β-Catenin and
    LEF-1 to increase transcription of EpCAM target genes, such as c-Myc and Cyclins
    A/E. Dkk2, Dickkopf2; Lrp6, Lipoprotein-receptor-related protein 6; EpCAM, epithelial
    cell adhesion molecule; PKC, protein kinase C; ERK, extracellular signal regulated
    kinase; ERas, embryonic Ras; AKT, RAC-α serine/threonine-protein kinase; EpICD,
    intracellular domain of EpCAM; FHL, four and a half LIM domains; LEF-1, lymphoid
    enhancer binding factor 1.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Epcam
  - Eam
  - Dkk2
  - Psen2
  - Lrp6
  - Fhl2
  - Ephb2
  - Mapk1
  - Akt1
  - Apc
  - Axin1
  - Ctnnb1
  - Lef1
  - pc
  - pk
  - Eras
  - EPCAM
  - DKK2
  - PSEN2
  - TFF1
  - TAS2R64P
  - LRP6
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - CDH1
  - CDH10
  - CDH11
  - CDH12
  - CDH13
  - CDH15
  - CDH16
  - CDH17
  - CDH18
  - CDH19
  - CDH2
  - CDH20
  - CDH22
  - CDH24
  - CDH3
  - CDH4
  - CDH5
  - CDH6
  - CDH7
  - CDH8
  - CDH9
  - FHL2
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - MYH14
  - MYO6
  - MYO10
  - MYO16
  - MYO19
  - MYH1
  - MYH10
  - MYH11
  - MYH13
  - MYH15
  - MYH16
  - MYH2
  - MYH3
  - MYH4
  - MYH6
  - MYH7
  - MYH7B
  - MYH8
  - MYH9
  - MYO1A
  - MYO1B
  - MYO1C
  - MYO1D
  - MYO1E
  - MYO1F
  - MYO1G
  - MYO1H
  - MYO3A
  - MYO3B
  - MYO5A
  - MYO5B
  - MYO5C
  - MYO7A
  - MYO7B
  - MYO9A
  - MYO9B
  - MYO15A
  - MYO15B
  - MYO18A
  - MYO18B
  - MYL1
  - MYL3
  - MYL4
  - MYL6
  - MYL6B
  - MYL10
  - MYL12A
  - MYL12B
  - MYL2
  - MYL5
  - MYL7
  - MYL9
  - MYL11
  - EPHB2
  - MAPK1
  - MAPK3
  - AKT1
  - AKT2
  - AKT3
  - APC
  - PROC
  - AXIN1
  - AXIN2
  - CTNNB1
  - LEF1
  - PC
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - ERAS
  - Tff1
  - Wnt2
  - Ephb1
  - Pc
  - Prkcg
  - epcam
  - dkk2
  - lrp6
  - lrp5
  - apc
  - ctnnb1
  - lef1
  - epcam.L
  - epcam.S
  - dkk2.L
  - dkk2.S
  - tff3.1.S
  - tff3.2.S
  - lrp6.L
  - lrp6.S
  - mapk1.L
  - mapk1.S
  - apc.L
  - axin1.S
  - ctnnb1.S
  - ctnnb1.L
  - lef-1
  - lef1.L
  - lef1.S
  - tbxt.S
  - tbxt.L
  - if
  - arr
  - Wnt5
  - Wnt4
  - wg
  - Pkc98E
  - fz
  - sqh
  - Mhc
  - Mlc2
  - Erk7
  - rl
  - Akt
  - Apc2
  - Axn
  - Fs(3)Apc
  - arm
  - pan
  - inaC
  - aPKC
  - Pkc53E
  - Cancer
---
